ARTIFICIALCELLS,NANOMEDICINE,ANDBIOTECHNOLOGY61
ChenJY,ScerboM,KramerG.2009.Areviewofbloodsubstitutes:
inclinicaltrialssuchasischemiareperfusioninjuriesand
examiningthehistory,clinicaltrialresults,andethicsofhemoglobin-
myocardialinfarction(Jainetal.2015).So,itisnecessaryto
basedoxygencarriers.Clinics.64:803–813.
monitorthefreeradicalsscavengingintheresearchofHBOCs
EvelynKA,MalloyHT.1938.Microdeterminationofoxyhemoglobin,
antioxidant.Vchasbeenprovedtobeaneffectivefreeradicals
methemoglobin,andsulfhemoglobininsingleofblood.BiolChem.
126:655–662.
scavengeranditsreactionwithfreeradicalsshouldcertainlybe
GreenburgAG.2009.Theidealbloodsubstitute.CritCareClin.25:415–424.
inclusioninthestudyofantioxidantprocess.Therefore,the
FontesP,LopezR,PlaatsA,VodovotzY,MinerviniM,ScottV.2014.Liver
mechanismsoffreeradicalscleaningoutinHBOCssolution
preservationwithmachineperfusionandanewlydevelopedcell-free
byVcwouldbethefuturework,whichwilldeepenthe
oxygencarriersolutionundersubnormothermicconditions.AmJ
understandingabouttheantioxidantofHBOCsbyVcandTransplant.15:381–394.
FronticelliC,KoehlerRC.2009.Designofrecombinanthemoglobinforuse
enhancingtheantioxidantprotectioneffectsofVconHBOCs.
intransfusionfluids.CritCareClin.25:357–371.
JahrJS,WalkerV,ManoochehriK.2007.Bloodsubstitutesaspharma-
cotherapiesinclinicalpractice.CurrOpinAnaesthesiol.20:325–330.
Declarationofinterest
JainAK,MehraNK,SwarnakarNK.2015.Roleofantioxidantforthe
ThisstudywasfinanciallysupportedbytheSichuanInternationaltreatmentofcardiovasculardiseases:challengesandopportunities.Curr
CooperationandExchangeResearchProgram(No.2014HH0065),SichuanPharmDes.21:1–15.
ScienceandTechnologySupportProgram(No.2014SZ0123),ScientificKaramianR,KomakiA,SalehiI,TahmasebiL,KomakiH,ShahidiS,SarihiA.
ResearchProgramofSichuanProvincialHealthandFamilyPlanning2015.VitaminCreversedlead-induceddeficitsinhippocampalsynaptic
Commission(No.150256).plasticityinrats.BrainResBull.116:7–15.
KleinhansH,MannO,SchurrPG,KaifiJT,HansenB,IzbickiJR,StrateT.2006.
Oxygenradicalformationdoesnothaveanimpactinthetreatmentof
References
severeacuteexperimentalpancreatitisusingfreecellularhemoglobin.
WorldJGastroenterol.12:2914–2918.
AlayashAI.2014.BloodSubstitutes:whyhaven’twebeenmoresuccessful?
LiT,ZhangZ,LiaoD,ChenY,YangC,XuX,LiuJ.2012.Theeffectof
TrendsBiotechnol.32:177–185.
polymerizedplacentahemoglobinonrenalischemia/reperfusioninjury.
AllenCJ,TashiroJ,ValleEJ,ThorsonCM,ShariatmadarS,SchulmanCI,etal.
ArtifCellsNanomedBiotechnol.40:396–399.
2014.Initialhematocritpredictstheuseofbloodtransfusioninthe
OrtizD,BarrosM,YanS,CabralesP.2014.Resuscitationfromhemorrhagic
pediatrictraumapatient.JPediatrSurg.49:1678–1682.
shockusingpolymerizedhemoglobincomparedtoblood.AmJEmerg
AtyabiN,YasiniSP,JalaliSM,ShayganH.2012.Antioxidanteffectof
Med.32:248–255.
differentvitaminsonmethemoglobinproduction:aninvitrostudy.
RempfC,StandlT,SchenkeK,ChammasK,GottschalkA,BurmeisterMA,
VetResForum.3:97–101.
GottschalkA.2014.Administrationofbovinepolymerizedhaemoglobin
BianY,ChangTM.2015.Anovelnanobiotherapeuticpoly-[hemoglobin-
beforeandduringcoronaryocclusionreducesinfarctsizeinrabbits.BrJ
superoxidedismutase-catalase-carbonicanhydrase]withnocardiac
Anaesth.103:496–504.
toxicityfortheresuscitationofaratmodelwith90minutesofsustained
SilvermanTA,WeiskopfRB.2009.Hemoglobin-basedoxygencarriers:
severehemorrhagicshockwithlossof2/3bloodvolume.ArtifCells
currentstatusandfuturedirections.Transfusion.49:2495–2515.
NanomedBiotechnol.43:1–9.
SuX,GuoS,HuangX,WangX,QiD,YangC.2014.Controlofoxidative
BianY,RongZ,ChangTM.2012.Polyhemoglobin-superoxidedismutase-
reactionsofhemoglobininthedesignofbloodsubstitutes:roleofthe
catalase-carbonicanhydrase:anovelbiotechnology-basedbloodsubsti-
Vc,NAC,TEMPOandtheirreductantsystem.ArtifCellsNanomed
tutethattransportsbothoxygenandcarbondioxideandalsoactsasan
Biotechnol.42:222–228.
antioxidant.ArtifCellsNanomedBiotechnol.39:127–136.
VermeijdenWJ,KlarenboschJV,GuYJ,MarianiMA,BuhreWF,ScheerenTL,
BuehlerPW,D’AgnilloF,SchaerDJ.2010.Hemoglobin-basedoxygen
etal.2015.Effectsofcell-savingdevicesandfiltersontransfusionin
carrier:frommechanismsoftoxicityandclearancetorationaldrug
cardiacsurgery:amulticenterrandomizedstudy.AnnThoracSurg.
design.TrendsMolMed.16:447–457.
99:26–32.
Downloadedby[TheInstituteofBloodTransfusion,ChineseAcademyofMedicalSciences]at18:2512January2016 |
|
